A randomized phase II study of low-dose decitabine versus low-dose azacitidine in lower risk MDS and MDS/MPN
Jabbour, Elias, Short, Nicholas J., Montalban-Bravo, Guillermo, Huang, Xuelin, Bueso-Ramos, Carlos, Qiao, Wei, Yang, Hui, Zhao, Chong, Kadia, Tapan, Borthakur, Gautam, Pemmaraju, Naveen, Sasaki, Koji,Language:
english
Journal:
Blood
DOI:
10.1182/blood-2017-06-788497
Date:
August, 2017
File:
PDF, 429 KB
english, 2017